Evidence Synthesis
Matedocare's Gross Margin 29.89% accelerated to 32.94% in the previous quarter, before decelerating to 29.89% in the latest quarter.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:05
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Matedocare's Gross Margin 29.89% accelerated to 32.94% in the previous quarter, before decelerating to 29.89% in the latest quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 29.89 % | 32.94 | ▼ |
| MARGINAL_OPERATING_LEVERAGE | 32.94 % | -8.66 | ▲ |
| REVENUE_GROWTH_YOY | -28.1 % | — | - |
| PRICE_CHANGE_PERCENT | 4.734 % | — | - |
| DAILY_VOLUME | 30,604 shares | 45,713 | ▼ |
| CLOSE_PRICE | 1.77 INR | 1.69 | ▲ |